Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,866,590

« Back to Dashboard
Patent 5,866,590 protects GABITRIL and is included in one NDA. There have been two Paragraph IV challenges on Gabitril.

This patent has thirty patent family members in twenty-four countries.

Summary for Patent: 5,866,590

Title: Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
Abstract:The present invention provides a new stable pharmaceutical composition containing tiagabine hydrochloride as active ingredient.
Inventor(s): Svensson; J.o slashed.rgen Ryhl (Frederikssund, DK), Nygaard; Lars (Valby, DK), Andersen; Tina Meinertz (Hoersholm, DK), Weibel; Helle (Hilleroed, DK), Hjorth; Thyge Borup (Farum, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:08/945,585
Patent Claim Types:
see list of patent claims
Composition; Process; Formulation;
Patent Metrics:
Source: PatentQuant.com
Field: Not categorized
Back Citations: 4th percentile
Forward Citations: 1st percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
tiagabine hydrochloride
TABLET;ORAL020646-005Apr 16, 1999RXNo5,866,590► subscribe
tiagabine hydrochloride
TABLET;ORAL020646-001Sep 30, 1997RXYes5,866,590► subscribe
tiagabine hydrochloride
TABLET;ORAL020646-002Sep 30, 1997RXNo5,866,590► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 5,866,590

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark0523/95May 05, 1995
PCT Information
PCT FiledApril 29, 1996PCT Application Number:PCT/DK96/00192
PCT Publication Date:November 07, 1996PCT Publication Number: WO96/34606

International Patent Family for Patent: 5,866,590

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina003418► subscribe
Austria211911► subscribe
Australia5644196► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.